Valuation: Isodiol International Inc

Market Cap 3.91M 2.75M 2.41M 2.22M 2.06M 262M 3.96M 26.56M 10.34M 129M 10.33M 10.1M 447M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.42M 5.63M 5.18M 4.81M 613M 9.26M 62.03M 24.14M 301M 24.12M 23.59M 1.04B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
Manager TitleAgeSince
Chief Executive Officer - 2017-05-23
Director of Finance/CFO - -
Corporate Officer/Principal - 2018-08-29
Director TitleAgeSince
Director/Board Member - 2017-05-23
Director/Board Member - 2018-08-29
Director/Board Member - 2018-11-20
Change 5-day change 1-year change 3-year change Capi.($)
-3.58%+881.08% - - 128
+0.86%+1.55%-11.67%-4.90% 12.94B
+1.50%+0.68%-33.62%-55.63% 4.79B
+0.96%+3.80%-7.08%-2.70% 4.49B
+0.30%+5.58%+23.58%-1.26% 3.92B
+1.15%+1.67%+5.33%-37.13% 3.89B
+3.07%+5.48%-9.42%+6.42% 3.17B
+3.78%-11.63%-10.45%-14.58% 3.16B
+1.63%+2.24%-6.44%-22.75% 2.41B
+2.80%+7.03%-9.40%+39.83% 1.77B
Average +1.25%+6.12%-6.57%-10.30% 4.5B
Weighted average by Cap. +1.45%+5.31%-8.03%-12.37%

Financials

2018 2019
Net sales 19.14M 13.46M 11.79M 10.86M 10.08M 1.28B 19.4M 130M 50.58M 630M 50.54M 49.44M 2.18B 22.25M 15.65M 13.7M 12.62M 11.72M 1.49B 22.55M 151M 58.8M 733M 58.76M 57.47M 2.54B
Net income -36.02M -25.33M -22.19M -20.44M -18.97M -2.42B -36.51M -245M -95.2M -1.19B -95.14M -93.05M -4.11B -126M -88.55M -77.56M -71.43M -66.31M -8.45B -128M -855M -333M -4.15B -333M -325M -14.38B
Net Debt -15.55M -10.94M -9.58M -8.82M -8.19M -1.04B -15.76M -106M -41.1M -512M -41.07M -40.17M -1.78B 5.22M 3.67M 3.22M 2.96M 2.75M 350M 5.29M 35.46M 13.8M 172M 13.79M 13.49M 596M
Logo Isodiol International Inc
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-